Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Pemphigoid as a keyword and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2 entry on the site.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now displays Revision: v3.4.2 and no longer shows Revision: v3.4.1.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, which appears to be a minor backend/software update with no visible changes to study content or layout. (To avoid being alerted by small changes, set an alert condition by clicking below.)SummaryDifference0.1%

- Check67 days agoChange DetectedShow glossary is now displayed; new metadata labels include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 have been removed.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision identifiers updated to v3.3.4; previous v3.3.3 removed.SummaryDifference0.1%

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.